TAX PLANNING FOR THE BIOTECH & PHARMACEUTICAL INDUSTRIES
OCTOBER 1 & 2, 2012 - PHILADELPHIA, PA
In the past few years, very significant tax changes have occurred in the Biotech and Pharmaceutical industries. Recent developments in contract manufacturing, supply chain management, the treatment of and repatriation of intellectual property back to the U.S. are a few of the significant developments that will be discussed. Learn how these new developments, opportunities and pitfalls will impact stocks and intangible assets. Our panel of experts will discuss recent legislation, tax credits, IRS implications and recent activity by the IRS towards audit procedures. Download Brochure
This course is for biotech and pharmaceutical tax, finance and accounting executives, as well as, in-house counsel/corporate counsel representatives and others looking to gain a better understanding of the tax planning opportunities for U.S. multinationals in related industries with research and development and intellectual property with operations abroad. There is no advance preparation or prerequisites but an understanding of U.S. international taxation is recommended.
Earn Up to 13 CPE and 13/11 CLE Credits (50/60 minute State)
MONDAY, OCTOBER 1, 2012
8:00 AM Continental Breakfast & Registration
9:00 AM Overview of Recent Legislation & Tax Provisions
- An update on FDA regulations and guidance
- International Tax Reform
- FIN 48 and Tax Provisions
- Treatment of Intellectual Property
- The Impact of Reform on Biotech Patent Strategies
10:15 AM Refreshment Break
10:30 AM Development & Transfers of Intellectual Property
- Key Tax Considerations
- Treatment of IP-related of IP
- Sale versus License of IP
- Character, Source, Amortization
- Treatment of IP-related of IP
- Consideration for related party transactions
- Statutory and Regulatory Framework
- Definition of “Intangible Property”
- “All Substantial Rights” Standard
- Litigation Update
Brian Andreoli, Partner, Squire Sanders (US) LLP, New York, NY
12:15 PM Networking Luncheon
1:45 PM Licensing and Transfer Pricing Issues
- Scope of Section 482
- Alternatives for Cross-Border Use of IP
- Section 1.861-18 Rules
- Trademarks
- Specified Methods for Intangibles
3:00 PM Refreshment Break
3:15 PM Cost Sharing Regulations
- Overview – Core Concepts
- Requirements for a Cost Sharing Arrangement
- 2011 Final v. 2008 Temp. Regulations
- Grandfathered QCSAs
- New Specified Methods
- Case Studies
Kenneth P. Christman Jr., Executive Director, Ernst & Young LLP, Washington, DC
4:45 PM Question & Answers
5:00 PM Seminar adjourns for the day
TUESDAY, OCTOBER 2, 2012
8:00 AM Continental Breakfast
9:00 AM New Audit Focus and Resolving Tax Disputes
- IP valuation relied on Comparable Uncontrolled Transactions and Residual Profit Split Method
- IRS began exploring income, market cap methods, advancing these methods in examination settings
- Fast Track Settlement (FTS)
- Pre-Filing Agreements (PFA)
- CAP and Pre-CAP
- Utilization of Schedule UTP
10:30 AM Refreshment Break
10:45 AM Supply Chain Management
- Global Supply Chains
- Old new models
- New models
- Current trends in Supply Chain Management
- Tax overlay
- Tax planning is often overlooked
- Recent Developments in Contract Manufacturing
- Current “Best Practices” Structuring
- Overview of drivers
- Structures for global manufacturing
- Structures for global services
- New Trends
- OECD Pronouncements on Business Restructuring and Transfer Pricing Methods
- IRS on contract manufacturing regulations
- Realignment of APA program
Greg Bryant, Partner, Cherry Bekaert & Holland LLP, Raleigh, NC
12:15 PM Networking Luncheon
1:15 PM R&D Tax Credits & Recent Developments
- Research Credit Overview
- Legislative Update
- Current Audit Trends & Nexus Documentation Standard Recent Court Cases and Implications
- Uncertain Tax Positions
- Recommendations
- Status of Global R&D Incentives
- Biotech & Pharmaceutical Trends in R&D
2:15 PM Cross-Border Mergers & Acquisitions and International Restructurings
- Hot Topics in Transaction Forms
- Post-Acquisition Matters
- Impaired Investments
- Cash D Reorganizations
- Selected Stock Basis Issues
Devon Bodoh, Principal, KPMG LLP, Washington, DC
Greg Featherman, Senior Manager, KPMG LLP, Washington, DC
3:30 PM Seminar Concludes
CONFERENCE LOCATION
Sonesta Hotel Philadelphia (formerly the Crowne Plaza Hotel)
1800 Market Street
Philadelphia, PA 19103 Hotel
Reservations : 1-800-Sonesta or 215-561-7500
REGISTER NOW
Fill in the Form and Submit
Call: 877 500 1510
Email: register@networkingseminars.com
Pay with debit or credit card even if you don’t have a PayPal Account. Click on the Pay Now button and click on the “Don’t have a PayPal Account” link to pay securely with a credit or debit card.

